CROSS COUNTRY HEALTHCARE INC (CCRN) Stock Fundamental Analysis

NASDAQ:CCRN • US2274831047

8.61 USD
+0.25 (+2.99%)
At close: Feb 20, 2026
8.5 USD
-0.11 (-1.28%)
After Hours: 2/20/2026, 8:21:17 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall CCRN gets a fundamental rating of 5 out of 10. We evaluated CCRN against 102 industry peers in the Health Care Providers & Services industry. CCRN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CCRN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year CCRN was profitable.
  • CCRN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: CCRN reported negative net income in multiple years.
  • Of the past 5 years CCRN 4 years had a positive operating cash flow.
CCRN Yearly Net Income VS EBIT VS OCF VS FCFCCRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

  • The Return On Assets of CCRN (-2.91%) is worse than 62.75% of its industry peers.
  • CCRN has a Return On Equity (-3.84%) which is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 0.98%, CCRN perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
  • CCRN had an Average Return On Invested Capital over the past 3 years of 15.05%. This is significantly above the industry average of 9.00%.
  • The last Return On Invested Capital (0.98%) for CCRN is well below the 3 year average (15.05%), which needs to be investigated, but indicates that CCRN had better years and this may not be a problem.
Industry RankSector Rank
ROA -2.91%
ROE -3.84%
ROIC 0.98%
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
CCRN Yearly ROA, ROE, ROICCCRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • With a Operating Margin value of 0.56%, CCRN perfoms like the industry average, outperforming 40.20% of the companies in the same industry.
  • CCRN's Operating Margin has declined in the last couple of years.
  • The Gross Margin of CCRN (20.19%) is comparable to the rest of the industry.
  • CCRN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.56%
PM (TTM) N/A
GM 20.19%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
CCRN Yearly Profit, Operating, Gross MarginsCCRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • CCRN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • CCRN has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CCRN has been reduced compared to 5 years ago.
  • There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CCRN Yearly Shares OutstandingCCRN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CCRN Yearly Total Debt VS Total AssetsCCRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • CCRN has an Altman-Z score of 4.40. This indicates that CCRN is financially healthy and has little risk of bankruptcy at the moment.
  • CCRN has a better Altman-Z score (4.40) than 78.43% of its industry peers.
  • CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.4
ROIC/WACC0.11
WACC8.72%
CCRN Yearly LT Debt VS Equity VS FCFCCRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 3.45 indicates that CCRN has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.45, CCRN belongs to the top of the industry, outperforming 85.29% of the companies in the same industry.
  • A Quick Ratio of 3.45 indicates that CCRN has no problem at all paying its short term obligations.
  • CCRN's Quick ratio of 3.45 is amongst the best of the industry. CCRN outperforms 87.25% of its industry peers.
Industry RankSector Rank
Current Ratio 3.45
Quick Ratio 3.45
CCRN Yearly Current Assets VS Current LiabilitesCCRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • CCRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -82.86%.
  • Measured over the past years, CCRN shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.57% on average per year.
  • The Revenue for CCRN has decreased by -22.14% in the past year. This is quite bad
  • CCRN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.33% yearly.
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%

3.2 Future

  • CCRN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -33.46% yearly.
  • CCRN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.58% yearly.
EPS Next Y-76.58%
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
EPS Next 5YN/A
Revenue Next Year-20.04%
Revenue Next 2Y-13.03%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCRN Yearly Revenue VS EstimatesCCRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CCRN Yearly EPS VS EstimatesCCRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • CCRN is valuated quite expensively with a Price/Earnings ratio of 71.75.
  • CCRN's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of CCRN to the average of the S&P500 Index (26.99), we can say CCRN is valued expensively.
  • With a Price/Forward Earnings ratio of 71.34, CCRN can be considered very expensive at the moment.
  • CCRN's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of CCRN to the average of the S&P500 Index (28.06), we can say CCRN is valued expensively.
Industry RankSector Rank
PE 71.75
Fwd PE 71.34
CCRN Price Earnings VS Forward Price EarningsCCRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CCRN is valued cheaply inside the industry as 81.37% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, CCRN is valued cheaper than 92.16% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.18
EV/EBITDA 7.4
CCRN Per share dataCCRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • A cheap valuation may be justified as CCRN's earnings are expected to decrease with -33.46% in the coming years.
PEG (NY)N/A
PEG (5Y)2.92
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CCRN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CROSS COUNTRY HEALTHCARE INC

NASDAQ:CCRN (2/20/2026, 8:21:17 PM)

After market: 8.5 -0.11 (-1.28%)

8.61

+0.25 (+2.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-12
Earnings (Next)03-04
Inst Owners96.15%
Inst Owner Change-1.44%
Ins Owners6.14%
Ins Owner Change11.6%
Market Cap282.06M
Revenue(TTM)1.13B
Net Income(TTM)-15.68M
Analysts71.43
Price Target11.68 (35.66%)
Short Float %4.28%
Short Ratio1.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.09%
Min EPS beat(2)-118.38%
Max EPS beat(2)-19.79%
EPS beat(4)1
Avg EPS beat(4)-49.67%
Min EPS beat(4)-118.38%
Max EPS beat(4)5.59%
EPS beat(8)4
Avg EPS beat(8)-23.71%
EPS beat(12)7
Avg EPS beat(12)-12.92%
EPS beat(16)11
Avg EPS beat(16)-6.6%
Revenue beat(2)0
Avg Revenue beat(2)-8.46%
Min Revenue beat(2)-9.46%
Max Revenue beat(2)-7.46%
Revenue beat(4)0
Avg Revenue beat(4)-5.87%
Min Revenue beat(4)-9.46%
Max Revenue beat(4)-0.73%
Revenue beat(8)1
Avg Revenue beat(8)-3.08%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)6
Avg Revenue beat(16)-0.91%
PT rev (1m)0%
PT rev (3m)-36.67%
EPS NQ rev (1m)-1.41%
EPS NQ rev (3m)-36.4%
EPS NY rev (1m)0%
EPS NY rev (3m)-26.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.04%
Valuation
Industry RankSector Rank
PE 71.75
Fwd PE 71.34
P/S 0.25
P/FCF 6.18
P/OCF 5.2
P/B 0.69
P/tB 1.19
EV/EBITDA 7.4
EPS(TTM)0.12
EY1.39%
EPS(NY)0.12
Fwd EY1.4%
FCF(TTM)1.39
FCFY16.19%
OCF(TTM)1.66
OCFY19.23%
SpS34.42
BVpS12.46
TBVpS7.25
PEG (NY)N/A
PEG (5Y)2.92
Graham Number5.8
Profitability
Industry RankSector Rank
ROA -2.91%
ROE -3.84%
ROCE 1.39%
ROIC 0.98%
ROICexc 1.26%
ROICexgc 2.43%
OM 0.56%
PM (TTM) N/A
GM 20.19%
FCFM 4.05%
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
ROICexc(3y)15.28%
ROICexc(5y)13.73%
ROICexgc(3y)22.9%
ROICexgc(5y)20.79%
ROCE(3y)21.31%
ROCE(5y)19.23%
ROICexgc growth 3Y-75.41%
ROICexgc growth 5Y-32.32%
ROICexc growth 3Y-77.25%
ROICexc growth 5Y-30.83%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
F-Score5
Asset Turnover2.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 49.56%
Cap/Sales 0.76%
Interest Coverage 250
Cash Conversion 229.81%
Profit Quality N/A
Current Ratio 3.45
Quick Ratio 3.45
Altman-Z 4.4
F-Score5
WACC8.72%
ROIC/WACC0.11
Cap/Depr(3y)64.63%
Cap/Depr(5y)60.57%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
EPS Next Y-76.58%
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%
Revenue Next Year-20.04%
Revenue Next 2Y-13.03%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A
EBIT growth 1Y-52.34%
EBIT growth 3Y-79.54%
EBIT growth 5Y-27.01%
EBIT Next Year494.68%
EBIT Next 3Y80.04%
EBIT Next 5YN/A
FCF growth 1Y-79.94%
FCF growth 3YN/A
FCF growth 5Y112.02%
OCF growth 1Y-77.47%
OCF growth 3YN/A
OCF growth 5Y85.29%

CROSS COUNTRY HEALTHCARE INC / CCRN FAQ

What is the ChartMill fundamental rating of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CCRN.


What is the valuation status for CCRN stock?

ChartMill assigns a valuation rating of 3 / 10 to CROSS COUNTRY HEALTHCARE INC (CCRN). This can be considered as Overvalued.


Can you provide the profitability details for CROSS COUNTRY HEALTHCARE INC?

CROSS COUNTRY HEALTHCARE INC (CCRN) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for CCRN stock?

The Earnings per Share (EPS) of CROSS COUNTRY HEALTHCARE INC (CCRN) is expected to decline by -76.58% in the next year.